Xuyao Zhang

16PUBLICATIONS
26CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Plant cell and molecular biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Dec 22, 2025
Scarless circular mRNA-based CAR-T cell therapy elicits superior antitumor efficacy.

Qinchao Hu, Hui Zhao, Kaicheng Zhou

|May 29, 2025
Nanobody-Directed CEA-Targeting CAR T Cells Eliminate Gastrointestinal Cancer Xenografts.

Zijie Feng, Xuyao Zhang, Zhicheng Peng

|Apr 24, 2025
USP14-IMP2-CXCL2 axis in tumor-associated macrophages facilitates resistance to anti-PD-1 therapy in gastric cancer by recruiting myeloid-derived suppressor cells.

Li You, Qian Wang, Tianxue Zhang

|Sep 28, 2024
Targeting CD47 and Angiogenesis Demonstrates Effective Anti-Tumor Effect in Bladder Cancer.

Xiting Huang, Qian Wang, Yanyang Nan

|Sep 04, 2024
Targeting IL-33 reprograms the tumor microenvironment and potentiates antitumor response to anti-PD-L1 immunotherapy.

Yanyang Nan, Yu Bai, Xiaozhi Hu

|Sep 03, 2024
Enhancing antitumor efficacy of CLDN18.2-directed antibody-drug conjugates through autophagy inhibition in gastric cancer.

Wenjing Xue, Caili Xu, Kaiqi Zhang

Pageof 3

Frequent Collaborators

4 joint publications

Zijie Feng

3 joint publications

Xin He

3 joint publications

Dianwen Ju

3 joint publications

Carl H June